series-a
Stage
1
Investors
About
Nitrase Therapeutics develops novel therapeutics by leveraging its proprietary NITROME platform to discover and exploit nitrase enzymes involved in various diseases, including Parkinson's disease.
Explore Nitrase Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.